Skip to main content

Table 3 Hospital treatment

From: Medical care of acute myocardial infarction patients in a resource limiting country, Trinidad: a cross-sectional retrospective study

Indicator EBG Treatment (commencement) ED treatment, % use in study In-patient treatment, % use in study
Drugs Dose (commencement)  
Aspirin 300 mg then 81 mg daily (Day 1) 97.2 963(87.1)
Clopidogrel 300 mg then 75 mg daily (Day 1) 97.2 964(87.2)
Enoxaparin (Heparin) 1 mg/kg twice daily (Day 1) 81.3 80.6
ACE inhibitor/ARB Initiate with low dose and titrate upwards (Day 1) NA 806(72.9)
Beta blocker Initiate with low dose and titrate upwards (Day 1) 30.3 846(76.5)
Statin Night time max tolerated dose (Day 1) NA 913(82.5)
Primary PCI Not applicable (not a PCI center) NA NA
Nitrates As required 15.0 809(73.1)
Investigations
 ECG Daily (Day 1) at least 2 100.0 NA
 Cardiac enzymes Daily (Day 1) at least 2 67.3 1106(100)
 Echocardiogram Prior to discharge NA 632(57.1)
 EST If necessary NA NA
Risk stratification
 TIMI or GRACE score or other Within 24 h NA NA
Surgical intervention
 Early invasive NSTEMI Intermediate- and high-risk patient: 24 to 48 h of admission Nil Nil
 Late invasive NSTEMI Low-risk patient: 25 to 72 h of admission Nil Nil
Lifestyle counseling
 Diet Hospital stay Nil 4.8
 Smoking Hospital stay Nil 1.9
 Exercise Hospital stay Nil 1.3
 Daily activity Hospital stay Nil 0.0–0.6
Cardiac rehab initiated Hospital stay Nil 0.0
Discharge medication Pharmacist review day 4 and before discharge Nil Nil
  1. ACE angiotensin-converting enzyme, ARB angiotensin II receptor blocker, ECG electrocardiogram, EST exercise stress test, GRACE Global Registry of Acute Coronary Events, HR heart rate, NSTEMI non-ST-elevation myocardial infarction, PCI percutaneous coronary intervention, STEMI ST-elevation myocardial infarction, TIMI Thrombolysis in Myocardial Infarction, NA Treatment not available or missing data